Ontology highlight
ABSTRACT:
SUBMITTER: Parikh M
PROVIDER: S-EPMC7164329 | biostudies-literature | 2020 Jan
REPOSITORIES: biostudies-literature
Parikh Mamta M Bajwa Poornima P
Seminars in nephrology 20200101 1
Immune checkpoint inhibitors have quickly become a critical component to the management of advanced renal cell carcinoma. These therapies have been approved for patients who are treatment-naive and who have progressed on antiangiogenesis agents. Combinations of immune checkpoint inhibitors with antiangiogenesis agents show significant response rates and prolong survival. Adverse events associated with the use of checkpoint inhibition present unique challenges in the management of patients, and c ...[more]